Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers
Melanie A. Price(The University of Sydney), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Daniel Costa(The University of Sydney), Madeleine King(The University of Sydney), Lynley Aldridge(The University of Sydney), Phyllis Butow(Royal Prince Alfred Hospital), Joanna E. Fardell(UNSW Sydney), Anna DeFazio(The University of Sydney)
Cited by 116
Related Papers
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovary
|The Journal of Pathology|2010|836
Type I and II Endometrial Cancers: Have They Different Risk Factors?
|Journal of Clinical Oncology|2013|833
Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary
|New England Journal of Medicine|2009|775